Financials
- Market Capitalization 15.64 B
- Employee 2 500
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
24.68
売上高対価格比率
5.15
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 477 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.04 USD | 0.00% | -1.04% | +4.94% | +27.18% | 28.10 B USD | ||
| 618 | VTRS Viatris Inc. - Common Stock | 16.32 USD | -0.12% | -0.12% | -7.69% | +57.68% | 18.75 B USD | ||
| 822 | ELAN Elanco Animal Health Incorporated Common Stock | 23.88 USD | -1.00% | -1.16% | -9.55% | +6.63% | 11.93 B USD | ||
| 907 | RDY Dr. Reddy's Laboratories Ltd | 12.17 USD | -0.08% | -0.41% | +1.67% | -14.30% | 10.16 B USD |